Adrenocortical carcinoma, hereditary: genes and variants
Explore variant evidence for Adrenocortical carcinoma, hereditary across 1 analyzed protein (TP53). Linked ClinVar records include 23 pathogenic or likely pathogenic variants, 34 variants of uncertain significance and 50 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Adrenocortical carcinoma, hereditary
TP53: Cellular tumor antigen p53
It coordinates transcriptional responses to DNA damage and other cellular stresses, promoting cell-cycle arrest, senescence, DNA repair, or apoptosis when appropriate. Loss of this tumor-suppressive control is one of the most common events in cancer, while germline pathogenic variants cause Li-Fraumeni syndrome.
23 ClinVar pathogenic / likely pathogenic and 84 uncertain variants in TP53 have source records linked to Adrenocortical carcinoma, hereditary. Association strength is not clinical gene validity.
Where Adrenocortical carcinoma, hereditary variants cluster
- TP53 DNA binding (positions 102–292): 20 of 20 ClinVar pathogenic / likely pathogenic variants, 2.1× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Adrenocortical carcinoma, hereditary
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TP53 H179Y | 179 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 G245D | 245 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 G245V | 245 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 V216M | 216 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 C238Y | 238 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 G244S | 244 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 R273C | 273 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 R273G | 273 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 H179D | 179 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 D281A | 281 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 P151T | 151 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 Y220H | 220 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 M237I | 237 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 D281V | 281 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 G105S | 105 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 L130P | 130 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 V143M | 143 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 A159V | 159 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 R267G | 267 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 G112S | 112 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 K132R | 132 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 R273L | 273 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 R282P | 282 | DNA binding | Pathogenic / likely pathogenic (★★) |
Which prediction tools work for Adrenocortical carcinoma, hereditary
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- AlphaGenome (regulatory): 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 94 out of 100
- EVE: 91 out of 100
- SIFT: 90 out of 100
- CADD: 89 out of 100
- REVEL: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 85 out of 100
- DMS / MaveDB: 62 out of 100
- Pangolin: 61 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 57 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaGenome (splicing): 53 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 47 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Li-Fraumeni syndrome also has ClinVar records linked to TP53 variants; they fall partly in the same places as the Adrenocortical carcinoma, hereditary variants (188 pathogenic / likely pathogenic).
- Acute myeloid leukemia also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Adrenocortical carcinoma, hereditary variants (6 pathogenic / likely pathogenic).
- Hereditary breast ovarian cancer syndrome also has ClinVar records linked to TP53 variants; they fall in the same places as the Adrenocortical carcinoma, hereditary variants (6 pathogenic / likely pathogenic).
- Breast and/or ovarian cancer also has ClinVar records linked to TP53 variants; they fall in the same places as the Adrenocortical carcinoma, hereditary variants (3 pathogenic / likely pathogenic).
Diseases related to Adrenocortical carcinoma, hereditary
- Li-Fraumeni syndrome, also linked to TP53
- Acute myeloid leukemia, also linked to TP53
- Hereditary breast cancer, also linked to TP53
- Hereditary breast ovarian cancer syndrome, also linked to TP53
- Colorectal cancer, also linked to TP53
- Gastric cancer, also linked to TP53
- Urinary bladder cancer, also linked to TP53
- Glioma susceptibility, also linked to TP53
- Multiple myeloma, also linked to TP53
- Ovarian neoplasm, also linked to TP53
- Lung adenocarcinoma, also linked to TP53
- Hepatocellular carcinoma, also linked to TP53
Frequently asked questions
Which genes have records linked to Adrenocortical carcinoma, hereditary?
This view contains 1 analyzed proteins: TP53. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 23 pathogenic or likely pathogenic variants, 34 variants of uncertain significance and 50 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 109 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center